Periodontal Disease, Periodontitis (Stage 3), Periodontitis Stage III
Conditions
Keywords
Low-density lipoprotein receptor-associated protein 5, Tryptophan Hydroxylase 1, Periodontitis
Brief summary
Objectives: The aim of this study was to determine the changes in LRP5 and TPH1 levels in serum and saliva samples due to periodontal inflammation and to evaluate the relationship between these values and clinical periodontal parameters. Methods: Saliva and serum samples were collected from 20 systemically healthy patients with Stage III periodontitis and 20 periodontally healthy control individuals. Salivary and serum LRP5 and TPH1 levels were analyzed using enzyme-linked immunosorbent assay (ELISA). Clinical periodontal parameters, including plaque index (PI), probing pocket depth (PPD), bleeding on probing (BOP), and clinical attachment level (CAL), were recorded.
Interventions
None listed
Sponsors
The Scientific and Technological Research Council of Turkey
Ankara University
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
* \>18 years old, * At least 16 permanent teeth except 3rd molars, * Individuals who do not use orthodontic appliances, * Individuals who are not pregnant or lactating, * Individuals without any systemic disease that may affect periodontal health, * Systemically healthy individuals, * Individuals who have not used anti-inflammatory and/or anti-microbial drugs in the last 6 months, * Individuals who have not received periodontal treatment in the last 1 year
Exclusion criteria
* Pregnant/lactating individuals, * Individuals who have used anti-inflammatory and/or anti-microbial drugs in the last 6 months, * Individuals who have undergone periodontal treatment in the last 1 year, * Individuals with psychiatric illness, * Individuals with any oral infection, * Individuals with \<16 teeth, excluding molars, * Individuals with alcohol dependence, * Individuals with active infectious disease (acute hepatitis, AIDS, tuberculosis), cancer or any systemic condition that may affect periodontal tissues, * Individuals receiving treatment with drugs known to affect periodontal tissues (phenytoin, cyclosporine A, calcium channel blockers)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| LRP5 | 1 month | Low-density lipoprotein (LDL) receptor-related protein 5 (LRP5) is a WNT coreceptor in the LRP superfamily involved in a wide range of biological processes including endocytosis, cellular communication, lipid homeostasis and embryonic development. The levels of LRP5 in both serum and saliva samples were determined using commercially available ELISA kits. All assays were conducted according to the manufacturers' instructions. |
| TPH1 | 1 month | The inhibitory, irreversible enzyme of serotonin synthesis from intestinal cells is tryptophan hydroxylase 1 (TPH1). The levels of TPH1 in both serum and saliva samples were determined using commercially available ELISA kits. All assays were conducted according to the manufacturers' instructions. |
Countries
Turkey (Türkiye)
Outcome results
None listed